Purchase Order 70Z02324P91230001
Award Date
9/13/24
Potential Completion Date
9/13/24
Potential Value
$100K
Federal Agency
Coast Guard
Awardee
Emergent Devices, Inc.
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Portsmouth, VA 23703, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Federal Emergency Management Agency (FEMA) to Emergent Devices, Inc., a for-profit pharmaceutical manufacturer, for the purchase of NARCAN nasal spray in support of FEMA's Environmental, Safety & Health Division operations. The award is for a Firm Fixed Price contract with a ceiling value of $18,995.76 and a completion date of June 1, 2024. Emergent Devices is a subsidiary of Emergent BioSolutions and is a key supplier of naloxone products to various...
This federal contract award to Emergent Devices, Inc., a for-profit pharmaceutical manufacturer, is for the provision of pharmaceuticals, specifically NARCAN nasal spray and other naloxone products, to various U.S. government agencies. The $226,140.00 Firm Fixed Price delivery order was awarded by the Department of Veterans Affairs' Veterans Integrated Service Network 12 and has a completion date of January 13, 2017. Emergent Devices holds two significant federal contract vehicles - an $11.8...
The Department of Homeland Security Customs and Border Protection awarded a firm-fixed-price delivery order to Emergent Devices, Inc., a for-profit manufacturer, for the provision of naloxone/NARCAN nasal spray. The $150,465.60 contract has an August 2019 completion date and is not set aside. Emergent Devices holds a Federal Supply Schedule pharmaceutical contract with the Department of Veterans Affairs and has also received federal grant sub-awards to support naloxone distribution efforts. This...
This federal contract award is for the delivery of NARCAN NASAL SPRAY to the Immigration and Customs Enforcement agency. The contract was awarded to Emergent Devices, Inc., a for-profit organization and manufacturer of pharmaceuticals and medical devices. The contract has a firm fixed price of $205,312.80 and was awarded on June 4, 2020, with a completion date of July 4, 2020. The contract is a delivery order under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) with the...
This is a $686,400.00 Delivery Order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Emergent Devices, Inc., a for-profit manufacturer of pharmaceutical goods. The contract is part of the VA's Federal Supply Schedule 65 IB for Pharmaceuticals and Drugs, which allows the agency to purchase naloxone nasal spray and other hematology-related products from Emergent Devices through August 2028. Emergent Devices has also received sub-awards from state health...
This federal contract award is for Emergent Devices, Inc. to procure 4,320 two-dose cycles (8,640 courses) of NARCAN (naloxone HCI) nasal spray 4mg applicator/cartridges for the U.S. Customs and Border Protection agency. The contract has a ceiling value of $162,820.80 and a completion date of September 30, 2024. This is a firm fixed-price delivery order contract with no set-aside designation. Emergent Devices, a for-profit pharmaceutical manufacturer, is the prime contractor on this award. The...
This is a $455,898.24 firm fixed-price purchase order contract awarded by the U.S. Department of Veterans Affairs (VA) to Emergent Devices, Inc., a pharmaceutical manufacturer, for the supply of NARCAN nasal spray, a naloxone product used to rapidly reverse opioid overdoses. The contract has an ultimate completion date of August 17, 2016 and was awarded on August 10, 2016 without any set-aside designation. Emergent Devices, a subsidiary of Emergent BioSolutions, is a key supplier of naloxone...
This federal contract award is for the delivery of NALOXONE INTERNASAL SPRAY in support of NATIONAL FENTANYL OPERATIONS, with a ceiling value of $19,900.32. The contract was awarded to Emergent Devices, Inc., a for-profit pharmaceutical manufacturer specializing in medical countermeasures, primarily naloxone products used to reverse opioid overdoses. The contract is a Delivery Order issued by the Department of Homeland Security's Immigration and Customs Enforcement (ICE) agency, with a place...
This is a federal contract award to Emergent Devices, Inc., a for-profit manufacturer, to provide naloxone nasal spray to the Department of Veterans Affairs Veterans Health Administration. The contract is a $934,875.00 delivery order under Emergent Devices' Federal Supply Schedule 61-IB contract for pharmaceuticals and drugs, which runs through August 2028. The naloxone nasal spray is used to rapidly reverse opioid overdoses and treat substance abuse. Emergent Devices has also received other...
The Department of Veterans Affairs Veterans Health Administration awarded a $934,410.48 firm fixed-price delivery order to Emergent Devices, Inc. for the provision of naloxone nasal spray. Naloxone is a medication that rapidly reverses opioid overdoses and treats substance abuse. The contract is under the Pharmaceuticals and Drugs Federal Supply Schedule, which allows Veterans Integrated Service Network 12 to procure pharmaceuticals through a streamlined vehicle. Emergent Devices, a for-profit...